Christopher M. Acker

2.7k total citations
26 papers, 2.1k citations indexed

About

Christopher M. Acker is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christopher M. Acker has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 12 papers in Molecular Biology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christopher M. Acker's work include Alzheimer's disease research and treatments (13 papers), Neuroscience and Neuropharmacology Research (7 papers) and CAR-T cell therapy research (4 papers). Christopher M. Acker is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Neuroscience and Neuropharmacology Research (7 papers) and CAR-T cell therapy research (4 papers). Christopher M. Acker collaborates with scholars based in United States, India and Canada. Christopher M. Acker's co-authors include Peter Davies, Karen Duff, Peter Davies, Patrick R. Hof, Yvonne Kress, Cathy Andorfer, Cristina d’Abramo, Sarah D. Schlatterer, Manuela Polydoro and Pablo E. Castillo and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Blood.

In The Last Decade

Christopher M. Acker

26 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher M. Acker United States	18	1.3k	762	635	576	549	26	2.1k
Giuseppina Tesco United States	27	1.4k 1.1×	1.2k 1.6×	619 1.0×	296 0.5×	370 0.7×	45	2.6k
David T. Winkler Switzerland	17	1.5k 1.2×	776 1.0×	448 0.7×	567 1.0×	664 1.2×	25	2.3k
Karelle Leroy Belgium	29	2.1k 1.7×	1.4k 1.8×	963 1.5×	639 1.1×	307 0.6×	60	3.2k
Julia E. Gerson United States	22	1.2k 1.0×	715 0.9×	439 0.7×	514 0.9×	443 0.8×	38	1.8k
Florian Plattner United States	26	752 0.6×	1.1k 1.4×	898 1.4×	232 0.4×	207 0.4×	39	2.3k
Shunsuke Koga United States	31	1.2k 0.9×	614 0.8×	689 1.1×	687 1.2×	1.9k 3.4×	107	2.9k
Marie L. Schmidt United States	17	1.3k 1.0×	615 0.8×	496 0.8×	451 0.8×	1.1k 2.0×	22	2.0k
Suizhen Lin United States	16	943 0.8×	738 1.0×	629 1.0×	833 1.4×	366 0.7×	24	2.2k
Ernesto R. Gonzales United States	19	608 0.5×	396 0.5×	231 0.4×	486 0.8×	173 0.3×	29	1.5k
Michèle Authelet Belgium	19	816 0.6×	478 0.6×	357 0.6×	310 0.5×	245 0.4×	22	1.4k

Countries citing papers authored by Christopher M. Acker

Since Specialization

Citations

This map shows the geographic impact of Christopher M. Acker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Acker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Acker more than expected).

Fields of papers citing papers by Christopher M. Acker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Acker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Acker. The network helps show where Christopher M. Acker may publish in the future.

Co-authorship network of co-authors of Christopher M. Acker

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Acker. A scholar is included among the top collaborators of Christopher M. Acker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Acker. Christopher M. Acker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tiwari, Ranjan, et al.. (2023). Leukapheresis and Tisagenlecleucel Manufacturing Outcomes in Patients Age <3 Years with Relapsed/Refractory Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 29(9). 579.e1–579.e10. 4 indexed citations

Willert, Jennifer, et al.. (2021). Tisagenlecleucel Leukapheresis and Manufacturing Outcomes in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia. Blood. 138(Supplement 1). 3882–3882. 2 indexed citations

Schmitt, David A., et al.. (2019). Autologous cryopreserved leukapheresis cellular material for chimeric antigen receptor–T cell manufacture. Cytotherapy. 21(12). 1198–1205. 31 indexed citations

Eldjerou, Lamis, Christopher M. Acker, Florence Salmon, et al.. (2019). Tisagenlecleucel Manufacturing Feasibility in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia. Blood. 134(Supplement_1). 5066–5066. 5 indexed citations

Mouzon, Benoit, Corbin Bachmeier, Joseph Ojo, et al.. (2018). Chronic White Matter Degeneration, but No Tau Pathology at One-Year Post-Repetitive Mild Traumatic Brain Injury in a Tau Transgenic Model. Journal of Neurotrauma. 36(4). 576–588. 37 indexed citations

Vingtdeux, Valérie, Haitian Zhao, Pallavi Chandakkar, et al.. (2016). A Modification-Specific Peptide-Based immunization Approach Using CRM197 Carrier Protein: Development of a Selective Vaccine Against Pyroglutamate Aβ Peptides. Molecular Medicine. 22(1). 841–849. 9 indexed citations

d’Abramo, Cristina, Christopher M. Acker, Heidy Jimenez, & Peter Davies. (2015). Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies. PLoS ONE. 10(8). e0135774–e0135774. 37 indexed citations

d’Abramo, Cristina, Christopher M. Acker, Joel B. Schachter, et al.. (2015). Detecting tau in serum of transgenic animal models after tau immunotherapy treatment. Neurobiology of Aging. 37. 58–65. 17 indexed citations

Koppel, Jeremy, Heidy Jimenez, Cristina d’Abramo, et al.. (2014). Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease. Behavioural Brain Research. 275. 27–33. 20 indexed citations

10.

Wu, Jessica, Mathieu Herman, Li Liu, et al.. (2012). Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons. Journal of Biological Chemistry. 288(3). 1856–1870. 408 indexed citations

11.

Weinger, Jason G., Peter Davies, Christopher M. Acker, et al.. (2012). Mice Devoid of Tau Have Increased Susceptibility to Neuronal Damage in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis. Journal of Neuropathology & Experimental Neurology. 71(5). 422–433. 26 indexed citations

12.

Acker, Christopher M., Stefanie Forest, Ray Zinkowski, Peter Davies, & Cristina d’Abramo. (2012). Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models. Neurobiology of Aging. 34(1). 338–350. 48 indexed citations

13.

Schlatterer, Sarah D., Hyeon-Sook Suh, Concepcion Conejero‐Goldberg, et al.. (2012). Neuronal c-Abl activation leads to induction of cell cycle and interferon signaling pathways. Journal of Neuroinflammation. 9(1). 208–208. 13 indexed citations

14.

Acker, Christopher M., Stefanie Forest, Ray Zinkowski, Peter Davies, & Cristina d’Abramo. (2012). P3‐004: Sensitive quantitative assays for tau and phospho‐tau in transgenic mouse models. Alzheimer s & Dementia. 8(4S_Part_12). 1 indexed citations

15.

Forest, Stefanie, Christopher M. Acker, Cristina d’Abramo, & Peter Davies. (2012). Methods for Measuring Tau Pathology in Transgenic Mouse Models. Journal of Alzheimer s Disease. 33(2). 463–471. 17 indexed citations

16.

Schlatterer, Sarah D., Christopher M. Acker, & Peter Davies. (2011). c-Abl in Neurodegenerative Disease. Journal of Molecular Neuroscience. 45(3). 445–452. 107 indexed citations

17.

Giliberto, Luca, Cristina d’Abramo, Christopher M. Acker, Peter Davies, & Luciano D'adamio. (2010). Transgenic Expression of the Amyloid-β Precursor Protein-Intracellular Domain Does Not Induce Alzheimer's Disease–Like Traits In Vivo. PLoS ONE. 5(7). e11609–e11609. 21 indexed citations

18.

Polydoro, Manuela, Christopher M. Acker, Karen Duff, Pablo E. Castillo, & Peter Davies. (2009). Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology. Journal of Neuroscience. 29(34). 10741–10749. 256 indexed citations

19.

Andorfer, Cathy, Christopher M. Acker, Yvonne Kress, et al.. (2005). Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms. Journal of Neuroscience. 25(22). 5446–5454. 396 indexed citations

20.

Vidt, Donald G., et al.. (1982). Duration of effect of single daily doses of reserpine and hydroflumethiazide evaluated by noninvasive technology in hypertensive patients. Cleveland Clinic Journal of Medicine. 49(4). 209–218. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact